Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease

por Galasko, Douglas, Xiao, Meifang, Xu, Desheng, Smirnov, Denis, Salmon, David P., Dewit, Nele, Vanbrabant, Jeroen, Jacobs, Dirk, Vanderstichele, Hugo, Vanmechelen, Eugeen, Worley, Paul
Publicado 2019

Phospho‐specific plasma p‐tau181 assay detects clinical as well as asymptomatic Alzheimer's disease

por De Meyer, Steffi, Vanbrabant, Jeroen, Schaeverbeke, Jolien M., Reinartz, Mariska, Luckett, Emma S., Dupont, Patrick, Van Laere, Koen, Stoops, Erik, Vanmechelen, Eugeen, Poesen, Koen, Vandenberghe, Rik
Publicado 2022

Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease

por Thijssen, Elisabeth H., Verberk, Inge M. W., Vanbrabant, Jeroen, Koelewijn, Anne, Heijst, Hans, Scheltens, Philip, van der Flier, Wiesje, Vanderstichele, Hugo, Stoops, Erik, Teunissen, Charlotte E.
Publicado 2021

Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia

por Thijssen, Elisabeth H., Verberk, Inge M.W., Kindermans, Jana, Abramian, Adlin, Vanbrabant, Jeroen, Ball, Andrew J., Pijnenburg, Yolande, Lemstra, Afina W., van der Flier, Wiesje M., Stoops, Erik, Hirtz, Christophe, Teunissen, Charlotte E.
Publicado 2022

Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231

por Bayoumy, Sherif, Verberk, Inge M. W., den Dulk, Ben, Hussainali, Zulaiga, Zwan, Marissa, van der Flier, Wiesje M., Ashton, Nicholas J., Zetterberg, Henrik, Blennow, Kaj, Vanbrabant, Jeroen, Stoops, Erik, Vanmechelen, Eugeen, Dage, Jeffrey L., Teunissen, Charlotte E.
Publicado 2021

Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease

por Janelidze, Shorena, Bali, Divya, Ashton, Nicholas J, Barthélemy, Nicolas R, Vanbrabant, Jeroen, Stoops, Erik, Vanmechelen, Eugeen, He, Yingxin, Dolado, Anna Orduña, Triana-Baltzer, Gallen, Pontecorvo, Michael J, Zetterberg, Henrik, Kolb, Hartmuth, Vandijck, Manu, Blennow, Kaj, Bateman, Randall J, Hansson, Oskar
Publicado 2022

Plasma p‐tau181/Aβ(1‐42) ratio predicts Aβ‐PET status and correlates with CSF‐p‐tau181/Aβ(1‐42) and future cognitive decline

por Fowler, Christopher J., Stoops, Erik, Rainey‐Smith, Stephanie R., Vanmechelen, Eugeen, Vanbrabant, Jeroen, Dewit, Nele, Mauroo, Kimberley, Maruff, Paul, Rowe, Christopher C., Fripp, Jurgen, Li, Qiao‐Xin, Bourgeat, Pierrick, Collins, Steven J., Martins, Ralph N., Masters, Colin L., Doecke, James D.
Publicado 2022

Combination of plasma amyloid beta((1-42/1-40)) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

por Verberk, Inge M. W., Thijssen, Elisabeth, Koelewijn, Jannet, Mauroo, Kimberley, Vanbrabant, Jeroen, de Wilde, Arno, Zwan, Marissa D., Verfaillie, Sander C. J., Ossenkoppele, Rik, Barkhof, Frederik, van Berckel, Bart N. M., Scheltens, Philip, van der Flier, Wiesje M., Stoops, Erik, Vanderstichele, Hugo M., Teunissen, Charlotte E.
Publicado 2020